Eric Rose

Chief Medical Officer / Mesoblast

Dr Eric Rose has experience as a surgeon, researcher and businessman; and has medical, pharmaceutical, scientific and industry expertise.

Dr Rose led the Columbia Presbyterian heart transplantation program in the United States from 1982 to 1992. He went on to become chair of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital from 1994 to 2007, and an Edmond A Guggenheim Professor and chair of the Department of Health Evidence and Policy at the Mount Sinai School of Medicine from 2008 to 2012.

Lists and Charts

Roles

2022

Chief Medical Officer

Mesoblast

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
16^th	Bellavista Resources	400.15%	0%
17^th	Nyrada Inc	399.89%	0%
18^th	Mesoblast	360.92%	0.62%
19^th	Petratherm	360.61%	40.77%
20^th	Chilwa Minerals	357.87%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	NEW ROLE: Chief Medical Officer, Mesoblast	21 Apr 2022
	REMUNERATION UPDATE: Non-Executive Director, Mesoblast	13 Nov 2020
	NEW ROLE: Non-Executive Director, Mesoblast	03 Nov 2020

Related Information

Access to our data for Eric Rose is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Eric Rose is linked to 2 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.